Characterization of new stable ghrelin analogs with prolonged orexigenic potency

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 3, 2012, Pages 781-786

  Maletínská, Lenka ^a   Pýchová, Miroslava ^a   Holubová, Martina ^a   Blechová, Miroslava ^a   Demianová, Zuzana ^a   Elbert, Tomáš ^a   Železná, Blanka ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYCLOHEXYLALANINE; DIAMINOPROPIONIC ACID; GHRELIN; GHRELIN DERIVATIVE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; NAPHTHYLALANINE; OCTANOIC ACID; PEPTIDE HORMONE; PROPIONIC ACID; SARCOSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STABILITY; GROWTH HORMONE RELEASE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; EATING; GHRELIN; GROWTH HORMONE; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, GHRELIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84857312620     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.185371     Document Type: Article

References (27)

1. Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, Warren VA, Howard AD, Van Der Ploeg LH, and Heck JV (2000) Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem 43:4370-4376. (Pubitemid 32046862)
2. Briggs DI and Andrews ZB (2011) Metabolic status regulates ghrelin function on energy homeostasis. Neuroendocrinology 93:48-57.
3. Castañeda TR, Tong J, Datta R, Culler M, and Tschöp MH (2010) Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 31:44-60.
4. Chang CH and Cheng YC (1978) Ribonucleotide reductase isolated from human cells. Heterogeneity among the sources. Biochem Pharmacol 27:2297-2300. (Pubitemid 9059434)
5. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. DeBoer MD (2008) Emergence of ghrelin as a treatment for cachexia syndromes. Nutrition 24:806-814.
7. Depoortere I (2009) Targeting the ghrelin receptor to regulate food intake. Regul Pept 156:13-23.
8. 125I]-IODO-GEN™ system. J Label Compd Radiopharm 53:288-293.
9. De Vriese C, Gregoire F, Lema-Kisoka R, Waelbroeck M, Robberecht P, and Delporte C (2004) Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145:4997-5005. (Pubitemid 39551118)
10. Guerlavais V, Boeglin D, Mousseaux D, Oiry C, Heitz A, Deghenghi R, Locatelli V, Torsello A, Ghé C, Catapano F, et al. (2003) New active series of growth hormone secretagogues. J Med Chem 46:1191-1203. (Pubitemid 36428224)
11. Kapica M, Laubitz D, Puzio I, Jankowska A, and Zabielski R (2006) The ghrelin pentapeptide inhibits the secretion of pancreatic juice in rats. J Physiol Pharmacol 57:691-700. (Pubitemid 46096114)
12. Kohno D, Gao HZ, Muroya S, Kikuyama S, and Yada T (2003) Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52:948-956. (Pubitemid 36384265)
13. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660. (Pubitemid 129516334)
14. Krasnow SM and Marks DL (2010) Neuropeptides in the pathophysiology and treatment of cachexia. Curr Opin Support Palliat Care 4:266-271.
15. Maixnerová J, Hlavácek J, Blokesová D, Kowalczyk W, Elbert T, Sanda M, BlechováM, Zelezná B, Slaninová J, and Maletínská L (2007) Structure-activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments. Peptides 28:1945-1953.
16. Maletínská L, Neugebauer W, Pérodin J, Lefebvre M, and Escher E (1997) Angiotensin analogues palmitoylated in positions 1 and 4. J Med Chem 40:3271-3279. (Pubitemid 27413752)
17. Matsumoto M, Hosoda H, Kitajima Y, Morozumi N, Minamitake Y, Tanaka S, Matsuo H, Kojima M, Hayashi Y, and Kangawa K (2001a) Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Commun 287:142-146. (Pubitemid 32912476)
18. Matsumoto M, Kitajima Y, Iwanami T, Hayashi Y, Tanaka S, Minamitake Y, Hosoda H, Kojima M, Matsuo H, and Kangawa K (2001b) Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues. Biochem Biophys Res Commun 284:655-659. (Pubitemid 32924779)
19. Morozumi N, Hanada T, Habara H, Yamaki A, Furuya M, Nakatsuka T, Inomata N, Minamitake Y, Ohsuye K, and Kangawa K (2011) The role of C-terminal part of ghrelin in pharmacokinetic profile and biological activity in rats. Peptides 32:1001-1007.
20. Nass R, Gaylinn BD, and Thorner MO (2011) The ghrelin axis in disease: potential therapeutic indications. Mol Cell Endocrinol 340:106-110.
21. Ohinata K, Kobayashi K, and Yoshikawa M (2006) [Trp3, Arg5]-ghrelin(1-5) stimulates growth hormone secretion and food intake via growth hormone secretagogue (GHS) receptor. Peptides 27:1632-1637. (Pubitemid 43866286)
22. Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, and Stricker-Krongrad A (2004) Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord 28:879-885. (Pubitemid 39005688)
23. Scerif M, Goldstone AP, and Korbonits M (2011) Ghrelin in obesity and endocrine diseases. Mol Cell Endocrinol 340:15-25.
24. Smith RG, Van der Ploeg LH, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ Jr, Fisher MH, Nargund RP, and Patchett AA (1997) Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645. (Pubitemid 27435537)
25. Torsello A, Ghe' C, Bresciani E, Catapano F, Ghigo E, Deghenghi R, Locatelli V, and Muccioli G (2002) Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology 143:1968-1971.
26. Van Craenenbroeck M, Gregoire F, De Neef P, Robberecht P, and Perret J (2004) Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor. Peptides 25:959-965. (Pubitemid 38760283)
27. Wisser A, Habbel P, Wiedenmann B, Klapp B, Mönnikes H, and Kobelt P (2010) Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists. Int J Pept 2010:817457.